Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSL Biotech is a life science software company best known as the original developer of SnapGene, a molecular biology software product used to plan, visualize, and document DNA cloning, PCR, plasmid design, and related workflows. The company served academic, biotech, and pharmaceutical researchers rather than developing therapeutics itself. Historical SBIR records show GSL Biotech also developed software projects such as "Kamino" for streamlining molecular biology project design, execution, and documentation. The business appears to have been acquired by GraphPad Software, and SnapGene is now operated within the broader GraphPad/Dotmatics scientific software portfolio. As a result, GSL Biotech is best characterized as an acquired, commercially oriented life science software company rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GSL Biotech.